Figure 2.

Prognostic relevance of CD133 expression levels across different types of tumor: (a) Kaplan–Meier plots demonstrated the different overall survival in CD133 highly expressed (red) and CD133 lowly expressed patients (blue) with LGG, SKCM, PRCC, ACC, PAAD, COAD, STAD, or LUAD. p value was generated from Log-rank test, and (b) Kaplan-Meier plots demonstrated the prognostic significance of CD133 expression levels in LGG in CGGA or GBM in CGGA, GSE7696 and GSE13041 datasets. The log-rank test was applied to compare the different overall survival of glioma patients with high CD133 expression levels (red) or low CD133 expression levels (blue).